Mark Manfredi is the founder of Ikena Oncology. Latest round: Seed. Backed by Ackermans & van Haaren, NRW.Bank, Sofinnova Partners. Based in Cologne, Germany.
Mark Manfredi brings over two decades of biopharmaceutical industry leadership and cancer drug discovery success. He holds a Ph.D. in biology from Boston College and a B.S. from the University of Rhode Island. Manfredi has served as CEO of Ikena Oncology and Chief Scientific Officer of Raze Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library